| Protein biomarkers for subtyping breast cancer and implications for future research C Mueller, A Haymond, JB Davis, A Williams, V Espina Expert review of proteomics 15 (2), 131-152, 2018 | 126 | 2018 |
| Synthesis and Bioactivity of β-Substituted Fosmidomycin Analogues Targeting 1-Deoxy-d-xylulose-5-phosphate Reductoisomerase R Chofor, S Sooriyaarachchi, MDP Risseeuw, T Bergfors, J Pouyez, ... Journal of medicinal chemistry 58 (7), 2988-3001, 2015 | 50 | 2015 |
| The effect of chain length and unsaturation on Mtb Dxr inhibition and antitubercular killing activity of FR900098 analogs ER Jackson, G San Jose, RC Brothers, EK Edelstein, Z Sheldon, ... Bioorganic & medicinal chemistry letters 24 (2), 649-653, 2014 | 37 | 2014 |
| Structure–activity relationships of the MEPicides: N-acyl and O-linked analogs of FR900098 as inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis G San Jose, ER Jackson, A Haymond, C Johny, RL Edwards, X Wang, ... ACS infectious diseases 2 (12), 923-935, 2016 | 34 | 2016 |
| MEPicides: α, β-unsaturated fosmidomycin analogues as DXR inhibitors against malaria X Wang, RL Edwards, H Ball, C Johnson, A Haymond, M Girma, ... Journal of medicinal chemistry 61 (19), 8847-8858, 2018 | 31 | 2018 |
| Design of potential bisubstrate inhibitors against Mycobacterium tuberculosis (Mtb) 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr)—evidence of a novel binding mode G San Jose, ER Jackson, E Uh, C Johny, A Haymond, L Lundberg, ... MedChemComm 4 (7), 1099-1104, 2013 | 30 | 2013 |
| Laser Capture Proteomics: spatial tissue molecular profiling from the bench to personalized medicine LA Liotta, PA Pappalardo, A Carpino, A Haymond, M Howard, V Espina, ... Expert review of proteomics 18 (10), 845-861, 2021 | 28 | 2021 |
| Kinetic Characterization and Allosteric Inhibition of the Yersinia pestis 1-Deoxy-D-Xylulose 5-Phosphate Reductoisomerase (MEP Synthase) A Haymond, C Johny, T Dowdy, B Schweibenz, K Villarroel, R Young, ... PLoS One 9 (8), e106243, 2014 | 24 | 2014 |
| Protein painting, an optimized MS-based technique, reveals functionally relevant interfaces of the PD-1/PD-L1 complex and the YAP2/ZO-1 complex A Haymond, D Dey, R Carter, A Dailing, V Nara, P Nara, S Venkatayogi, ... Journal of Biological Chemistry 294 (29), 11180-11198, 2019 | 21 | 2019 |
| Seropositivity of COVID-19 among asymptomatic healthcare workers: a multi-site prospective cohort study from Northern Virginia, United States AA Damluji, S Wei, SA Bruce, A Haymond, EF Petricoin, L Liotta, ... The Lancet Regional Health–Americas 2, 2021 | 13 | 2021 |
| A new structural model of apolipoprotein b100 based on computational modeling and cross linking K Jeiran, SM Gordon, DO Sviridov, AM Aponte, A Haymond, G Piszczek, ... International Journal of Molecular Sciences 23 (19), 11480, 2022 | 12 | 2022 |
| VOC fingerprints: Metabolomic signatures of biothreat agents with and without antibiotic resistance A Dailey, J Saha, F Zaidi, H Abdirahman, A Haymond, F Alem, R Hakami, ... Scientific Reports 10 (1), 11746, 2020 | 12 | 2020 |
| Proteomics for cancer drug design A Haymond, JB Davis, V Espina Expert review of proteomics 16 (8), 647-664, 2019 | 12 | 2019 |
| A secretory form of Parkin‐independent mitophagy contributes to the repertoire of extracellular vesicles released into the tumour interstitial fluid in vivo M Howard, J Erickson, Z Cuba, S Kim, W Zhou, P Gade, R Carter, ... Journal of Extracellular Vesicles 11 (7), e12244, 2022 | 9 | 2022 |
| Next-generation techniques for determination of protein-protein interactions: beyond the crystal structure R Carter, A Luchini, L Liotta, A Haymond Current pathobiology reports 7, 61-71, 2019 | 8 | 2019 |
| Serological testing for COVID-19 disease: Moving the field of serological surveillance forward AA Damluji, D Rajan, A Haymond, C deFilippi The journal of applied laboratory medicine 6 (3), 584-587, 2021 | 5 | 2021 |
| Structure–Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis. ACS Infect … G San Jose, ER Jackson, A Haymond, C Johny, RL Edwards, X Wang, ... DOI: https://doi. org/10.1021/acsinfecdis. 6b00125. PMID: https://www. ncbi …, 0 | 5 | |
| Identification of the functional PD-L1 interface region responsible for PD-1 binding and initiation of PD-1 signaling R Carter, F Alanazi, A Sharp, J Roman, A Luchini, L Liotta, M Paige, ... Journal of Biological Chemistry 299 (12), 2023 | 4 | 2023 |
| Clinical utility of a highly sensitive lateral flow immunoassay as determined by titer analysis for the detection of anti-SARS-CoV-2 antibodies at the point-of-care A Haymond, C Mueller, H Steinberg, KA Hodge, C Lehman, SC Lin, ... medRxiv, 2020.07. 30.20163824, 2020 | 4 | 2020 |
| A high-throughput screening campaign to identify inhibitors of DXP reductoisomerase (IspC) and MEP cytidylyltransferase (IspD) A Haymond, T Dowdy, C Johny, C Johnson, H Ball, A Dailey, ... Analytical biochemistry 542, 63-75, 2018 | 4 | 2018 |
